Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bgne crawled date : 2021 - 05 - 05 save search
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-05 (Crawled : 18:31) - fda.gov
PFE | News 4 | $26.27 -0.19% -0.38% 130K
|
Health Technology
|
| O: -3.73%
H: 1.95%
C: 1.85%
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: -0.65%
H: 1.33%
C: 1.22%
BMY | $46.72 -4.38% 2M
|
Health Technology
|
| O: -0.12%
H: 0.19%
C: -0.22%
ADCT | $4.65 -2.72% 19K
|
Health Technology
|
| O: 3.45%
H: 1.01%
C: -0.66%
ABBV | News | $168.67 0.52% 260K
|
Health Technology
|
| O: -0.67%
H: 1.03%
C: 0.94%
YMAB | $14.53 -4.97% 30K
|
Health Technology
|
| O: -0.85%
H: 2.64%
C: 2.1%
VSTM | $9.31 2.8K
|
Health Technology
|
| O: -2.03%
H: 0.82%
C: -1.72%
SNY | News | $46.61 -2.27% -2.21% 220K
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
RIGL | $1.125 -1.32% -1.33% 0
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.05%
REGN | News | $906.54 -0.09% -0.08% 62
|
Health Technology
|
| O: 0.14%
H: 4.11%
C: 3.22%
KPTI | $1.09 0.91% 8
|
Health Technology
|
| O: 0.37%
H: 1.11%
C: 0.0%
INCY | $51.74 0.17% 0.14% 2
|
Health Technology
|
| O: -0.09%
H: 1.99%
C: 1.35%
ILMN | $122.87 -1.28% -1.4% 330
|
Health Technology
|
| O: -0.64%
H: 0.34%
C: 0.31%
EXEL | $23.515 -0.82% 100K
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: -2.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -9.2%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.34%
H: 0.86%
C: -2.91%
BPMC | $92.26 -0.03% 0.02% 0
|
Health Technology
|
| O: -0.26%
H: 2.88%
C: 2.72%
BGNE | $148.04 2.72% 24K
|
Health Technology
|
| O: 0.14%
H: 3.67%
C: 2.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.3%
H: 0.15%
C: -1.78%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.03%
H: 0.88%
C: 0.81%
ALNY | $143.8 -1.55% -1.58% 50
|
Health Technology
|
| O: -0.51%
H: 1.52%
C: 0.08%
AGIO | $31.67 -0.44% -0.44% 0
|
Health Technology
|
| O: -0.45%
H: 4.45%
C: 3.9%
cancer approval
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
BGNE | $148.04 2.72% 24K
|
Health Technology
|
| O: -0.5%
H: 3.2%
C: -1.07%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.43%
H: 1.5%
C: 1.24%
new drug fda drug psoriasis fda acceptance application plague
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
ACON | $0.3595 24.83% 3.5M
|
n/a
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
TRU | $74.475 8.44% 100K
|
Technology Services
BQ | $0.279 7.31% 14K
|
Consumer Non-Durables
CASI | $2.61 6.97% 13K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.